Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Progyny, Inc. - Common Stock (NQ:PGNY)

22.55 -0.51 (-2.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
Progyny Inc (NASDAQ:PGNY) – A Prime Affordable Growth Stock with Strong Fundamentals and Fair Valuation
Progyny (PGNY) offers strong growth potential with 38% revenue growth, 32% EPS outlook, and fair valuation (P/E 24.75). Debt-free with solid profitability, it aligns with the Affordable Growth strategy... 
Via Chartmill
PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance
Fertility benefits company Progyny (NASDAQ:PGNY) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s... 
Via StockStory
The Analyst Verdict: Progyny In The Eyes Of 4 Experts
 
Via Benzinga
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s... 
Via StockStory
Progyny Earnings: What To Look For From PGNY
Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results this Thursday after market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
PROGYNY INC (NASDAQ:PGNY) Stands Out as a High-Quality Buy-and-Hold Stock with Strong Growth and Financial Health
The Caviar Cruise strategy identifies high-quality stocks like Progyny Inc (PGNY), excelling in revenue growth, ROIC, profit quality, and debt-free stability for long-term investors. 
Via Chartmill
3 Low-Volatility Stocks We Think Twice About
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Why Progyny (PGNY) Stock Is Up Today
Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the afternoon session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week of... 
Via StockStory
Why Progyny (PGNY) Stock Is Falling Today
Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 3.9% in the afternoon session after a regulatory filing revealed a significant institutional investor had sharply reduced its stake in... 
Via StockStory
Topics Artificial Intelligence
1 Value Stock with Impressive Fundamentals and 2 to Turn Down
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Under the Radar: Hunting Smart in the Alleyway of Value and Growth
 
Via Benzinga
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
1 Stock Under $50 with Exciting Potential and 2 to Question
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
1 Russell 2000 Stock to Consider Right Now and 2 to Keep Off Your Radar
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
1 Small-Cap Stock on Our Watchlist and 2 to Turn Down
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Progyny Stock Trades Higher On Collaboration With Amazon’s Health Benefits Connector: Retail’s Yet To Be Impressed
Through Amazon’s Health Benefits Connector, eligible individuals can now seamlessly enroll in Progyny benefits that are available to them through their employer or health plan. 
Via Stocktwits
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Retirement Stocks
Q1 Earnings Outperformers: Progyny (NASDAQ:PGNY) And The Rest Of The Health Insurance Providers Stocks
Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Progyny (NASDAQ:PGNY) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
3 Cash-Producing Stocks in the Doghouse
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 16.5% year on year to $324 million. The company expects next... 
Via StockStory
Progyny (NASDAQ:PGNY) Posts Better-Than-Expected Sales In Q1, Provides Optimistic Revenue Guidance for Next Quarter
Fertility benefits company Progyny (NASDAQ:PGNY) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.5% year on year to $324 million. On top of that, next quarter’s revenue guidance... 
Via StockStory
Progyny (PGNY) Reports Earnings Tomorrow: What To Expect
Fertility benefits company Progyny (NASDAQ:PGNY) will be reporting earnings tomorrow after the bell. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
3 Value Stocks Facing Headwinds
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Topics Economy
Health Insurance Providers Stocks Q4 Teardown: Humana (NYSE:HUM) Vs The Rest
Let’s dig into the relative performance of Humana (NYSE:HUM) and its peers as we unravel the now-completed Q4 health insurance providers earnings season. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Progyny (PGNY): Buy, Sell, or Hold Post Q4 Earnings?
Even during a down period for the markets, Progyny has gone against the grain, climbing to $22.52. Its shares have yielded a 40% return over the last six months, beating the S&P 500 by 54.3%. This was... 
Via StockStory
Topics Stocks Supply Chain
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.